Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.
about
Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatmentWhole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studiesRole of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast CancerImaging the lymphatic system.Preoperative axillary staging with 3.0-T breast MRI: clinical value of diffusion imaging and apparent diffusion coefficientLocoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy.The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registrationRole of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy.A new optical probe for the detection of the sentinel lymph node using patent blue V dye in breast cancer: A preliminary study.PET Probe-Guided Surgery in Patients with Breast Cancer: Proposal for a Methodological ApproachStaging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?The current status of positron emission mammography in breast cancer diagnosis.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Is imaging the future of axillary staging in breast cancer?Meta-analysis of ultrasound-guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer.Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.The role of magnetic nanoparticles in the localization and treatment of breast cancerMeta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients.Diagnostic implications of a small-voxel reconstruction for loco-regional lymph node characterization in breast cancer patients using FDG-PET/CT.Hybrid 18F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.What is the future of magnetic nanoparticles in the axillary management of breast cancer?The Japanese Breast Cancer Society clinical practice guidelines for screening and imaging diagnosis of breast cancer, 2015 edition.The roles of 18F-FDG-PET/CT and US-guided FNAC in assessment of axillary nodal metastases in breast cancer patients.The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer.¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.Preoperative PET/CT in early-stage breast cancer.Molekulare Brustbildgebung
P2860
Q26751999-DDF1BBAF-FAE9-4DEB-8C7B-B6A54518387BQ27009307-8DE1B591-B7F4-4D7F-9CDF-DADB8C3BA81DQ28079818-D9E18643-C73B-48A1-B5DE-CEA3A7C9154EQ30399978-84DAF367-8CA1-4FCD-AD38-3B4107198784Q35231495-BA379C4B-A31D-492C-B2B4-B8F426FF27B1Q35912778-A6A248FA-FCE2-444A-B659-E3381A6746F9Q36972681-D7C076EC-A5E3-41BC-8DAB-A33BD3828C4BQ37293618-7876A390-3BCE-4FAA-844E-4A22F625E78FQ37641062-D8F825E9-FD01-4748-8EFF-97C07D530AEEQ37705266-33DE3D48-00AC-4D3B-94BD-9ADE5B77E977Q37735166-6D3DA0E8-6118-4D9F-A9BA-90F8AD977010Q38067336-DDEECBB2-09CE-48F8-9FD1-F27898F37775Q38090509-A617CCB8-F063-4F49-9C5F-147318F4B373Q38137722-88C63125-EC51-4932-895E-6BEE43B43B32Q38263721-89FD4E7D-B879-4DA4-98CB-CD203C825161Q39685741-6A0434F3-2BC8-46A9-A694-8F8999358486Q42031750-43E03C2D-E689-4A93-B47F-C96098A09ADBQ46457073-5DCE051F-53E4-4943-A44B-A5E00A14005BQ48230339-62D640EA-7AD2-40F5-82AE-307F1C619B62Q48297177-FE9DF7DA-A7C8-4548-8E5D-175AF2FF97C7Q50100711-135D2646-7F2B-4F78-81BD-C181FD36AC9FQ51328839-69353AE6-4CE7-4EB2-B71F-22CBCCFB8D71Q52983883-163D17F4-B346-4BA1-BFCF-D4A4A288954AQ52984115-BB54917D-06E5-42E8-BABF-B0C384BFD401Q53057894-A50389D6-4174-452F-8A01-382DF8A51907Q53089607-C0914BD0-FBD4-461D-98FF-445253A6F731Q53174047-91CBAB16-BA5B-453E-AF71-C4DBA3201F53Q57712624-1666B6F0-4997-437F-AD45-D7A5861DDC84
P2860
Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Positron emission tomography ( ...... atic review and meta-analysis.
@ast
Positron emission tomography ( ...... atic review and meta-analysis.
@en
type
label
Positron emission tomography ( ...... atic review and meta-analysis.
@ast
Positron emission tomography ( ...... atic review and meta-analysis.
@en
prefLabel
Positron emission tomography ( ...... atic review and meta-analysis.
@ast
Positron emission tomography ( ...... atic review and meta-analysis.
@en
P2093
P50
P1476
Positron emission tomography ( ...... matic review and meta-analysis
@en
P2093
P304
P356
10.1016/J.EJSO.2011.01.003
P577
2011-01-26T00:00:00Z